An interventional study of SPARTA force plate in Total Joint Replacement Surgery, sponsored by Derek Amanatullah. Completed at 1 site in United States. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2023-03-24.
Sponsored by Derek Amanatullah · Not applicable, Interventional, and Supportive care
SPARTA force plate is used as rehabilitation tool in this study. The device is Force Plate coupled with SPARTA scan software that enables quick assessment of individual movement and balance within minutes. The magnitude as well as efficiency of force production is analyzed to determine an patient recovery graph.
The investigator hope to learn co-relation between the rehab tool and clinical findings and analyse association if any. In this study, force plate is rehab tool, which will optimize care according to the patient's specific needs and provided insights to patients length of stay in the hospital. these data driven insights will be used to observe correlation between machine and clinic data
Derek Amanatullah is the lead sponsor of 2 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients not willing and capable to sign the written informed consent
The application used is build upon the company's category-defining, SPARTA Platform and create a platform that streamlines the performance and management of post-acute care physical therapy. The rehab tool will provide us with functional outcome score.
Device: SPARTA force plate
The Sparta Platform includes force plate hardware coupled with Sparta Scan software that enables quick assessment of an individual's movement and balance within minutes
Length of Stay in Hospital Through Discharge
Length of stay will depend on the score generated by device.
Time frame: Up to 8 days
Gait Aid Use
The gait aide use ranges in the order of decreasing performance as Nothing \> Cane/Walking Sticks \> crutch \> walker.
Time frame: Preoperative and month 3 post-surgery
Knee Society Score (KSS)
To assess the effectiveness of the device by calculating Knee Society Score (KSS) at 3 months following surgery. The scale ranges from 0-100 with grading as: Score 80-100 - Excellent; Score 70-79 - Good; Score 60-69 - Fair; Score below 60 - Poor.
Time frame: Month 3 post-surgery
Range of Motion
To assess the effectiveness of the device by calculating range of motion (extension and flexion). Higher extension scores and lower flexion scores represent greater flexibility.
Time frame: Preoperative and month 3 post-surgery
| Milestone | Sparta Force Plate |
|---|---|
| Started | 40 |
| Completed | 40 |
| Not completed | 0 |
Length of stay will depend on the score generated by device.
| days | Sparta Force Plate |
|---|---|
| Length of Stay in Hospital Through Discharge | 3 (2 to 3) |
The gait aide use ranges in the order of decreasing performance as Nothing \> Cane/Walking Sticks \> crutch \> walker.
| Participants | Sparta Force Plate |
|---|---|
| Preoperative — None | 37 |
| Preoperative — Cane/Walking Sticks | 3 |
| Month 3 — None | 38 |
| Month 3 — Cane/Walking Sticks | 0 |
To assess the effectiveness of the device by calculating Knee Society Score (KSS) at 3 months following surgery. The scale ranges from 0-100 with grading as: Score 80-100 - Excellent; Score 70-79 - Good; Score 60-69 - Fair; Score below 60 - Poor.
| score on a scale | Sparta Force Plate |
|---|---|
| Knee Society Score (KSS) | 90.4 ± 11.39 |
To assess the effectiveness of the device by calculating range of motion (extension and flexion). Higher extension scores and lower flexion scores represent greater flexibility.
| degrees | Sparta Force Plate |
|---|---|
| Extension - preoperative | 2.4 ± 3.34 |
| Extension - month 3 | 0.3 ± 1.15 |
| Flexion - preoperative | 113.9 ± 11.78 |
| Flexion - month 3 | 116.0 ± 8.54 |
Collected over Up to 1 year. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Sparta Force Plate | 0/40 (0%) | 0/40 (0%) | 0/40 (0%) |
| Age, Continuous(years) | Sparta Force Plate |
|---|---|
| Mean | 64.83 ± 9.34 |
| Sex: Female, Male(Participants) | Sparta Force Plate |
|---|---|
| Female | 21 |
| Male | 19 |
| Ethnicity (NIH/OMB)(Participants) | Sparta Force Plate |
|---|---|
| Hispanic or Latino | 3 |
| Not Hispanic or Latino | 28 |
| Unknown or Not Reported | 9 |
| Race (NIH/OMB)(Participants) | Sparta Force Plate |
|---|---|
| American Indian or Alaska Native | 1 |
| Asian | 1 |
| Native Hawaiian or Other Pacific Islander | 0 |
| Black or African American | 1 |
| White | 28 |
| More than one race | 0 |
| Unknown or Not Reported | 9 |
| Region of Enrollment(Participants) | Sparta Force Plate |
|---|---|
| United States | 40 |
Documents are hosted by the registry — open the source record to download them.
This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Derek Amanatullah